delay in approval of tasigma
here are some delay news regarding fda approval of tasigma (amn-107)
i hope the delay will not be longer than the 3 months reported
best regards
giora
Reuters
Novartis cuts outlook, faces U.S. Tasigna delay
Tuesday July 17, 8:16 am ET
Novartis also said U.S. regulators had extended their review period for cancer
drug Tasigna by three months to review additional data. No new studies are
required